Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | VRDN | ZYME | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Viridian Therapeutics Inc | Zymeworks Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.18 | 17.15 | 23.53 | ||
| High | 3.28 | 17.44 | 23.59 | ||
| Low | 3.11 | 16.45 | 22.65 | ||
| Latest | 3.23 | 16.63 | 23.14 | ||
| Change | +0.12 | -0.08 | unch | ||
| % Change | +3.86% | -0.48% | unch | ||
| Volume | 24,853,701 | 4,032,000 | 699,000 | ||
| 20-Day Average Volume | 22,277,455 | 1,659,570 | 727,210 | ||
| Previous Close | 3.11 | 16.71 | 23.14 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.30 | 16.59 | 24.08 | ||
| 20-Day Raw Stochastic | 30.08% | 41.85% | 24.69% | ||
| 20-Day Relative Strength | 48.74 | 48.20 | 42.67 | ||
| Weighted Alpha | -38.24 | +2.39 | +52.40 | ||
| Today's Opinion | 96% Sell | 48% Sell | 8% Sell | ||
| Previous Opinion | 96% Sell | 48% Sell | 8% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.54% since 06/11/26 | +3.04% since 06/11/26 | +0.76% since 06/11/26 | ||
| Low | 3.07 on 06/17/26 | 15.96 on 06/16/26 | 22.14 on 06/16/26 | ||
| High | 3.39 on 06/15/26 | 17.44 on 06/18/26 | 23.59 on 06/18/26 | ||
| 1-Month | |||||
| %Chg | +11.76% since 05/18/26 | +3.29% since 05/18/26 | -5.28% since 05/18/26 | ||
| Low | 2.77 on 05/19/26 | 15.50 on 06/10/26 | 22.14 on 06/16/26 | ||
| High | 4.04 on 06/04/26 | 18.20 on 05/22/26 | 26.19 on 05/27/26 | ||
| 3-Month | |||||
| %Chg | -2.71% since 03/18/26 | -40.03% since 03/18/26 | -1.32% since 03/18/26 | ||
| Low | 2.77 on 05/19/26 | 13.18 on 04/29/26 | 22.14 on 06/16/26 | ||
| High | 4.04 on 06/04/26 | 28.59 on 03/25/26 | 29.75 on 04/27/26 | ||
| 6-Month | |||||
| %Chg | -27.25% since 12/18/25 | -47.37% since 12/18/25 | -12.35% since 12/18/25 | ||
| Low | 2.77 on 05/19/26 | 13.18 on 04/29/26 | 21.93 on 02/23/26 | ||
| High | 5.24 on 01/22/26 | 34.29 on 01/14/26 | 29.75 on 04/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,711,593 | 1,714,137 | 1,689,752 | ||
| Shares Outstanding, K | 529,905 | 103,075 | 73,023 | ||
| Annual Sales | 74,680,000 | 70,850,000 | 105,970,000 | ||
| Annual Net Income | -644,760,000 | -342,600,000 | -81,130,000 | ||
| Last Quarter Sales | 6,470,000 | 140,000 | 2,410,000 | ||
| Last Quarter Net Income | -117,500,000 | -104,900,000 | -44,160,000 | ||
| 60-Month Beta | 1.04 | 0.90 | 1.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 05/06/26 | -0.90 on 05/05/26 | -0.59 on 05/07/26 | ||
| Earnings Date | 08/04/26 | 08/05/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||